Stan Berenshteyn
Stock Analyst at Wells Fargo
(0.54)
# 2425
Out of 5,344 analysts
69
Total ratings
37.50%
Success rate
-7.42%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
OMCL Omnicell | Maintains: Overweight | 35 37 | 28.24 | 31.02% | 16 | May 23, 2025 | |
TDOC Teladoc Health | Maintains: Equal-Weight | 10 8 | 6.81 | 17.47% | 3 | May 8, 2025 | |
GDRX GoodRx Holdings | Maintains: Overweight | 8 7 | 3.75 | 86.67% | 8 | Apr 29, 2025 | |
HQY HealthEquity | Maintains: Overweight | 110 125 | 99.05 | 26.2% | 9 | Feb 26, 2025 | |
DOCS Doximity | Maintains: Equal-Weight | 43 55 | 51.07 | 7.7% | 10 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 13 10 | 3.67 | 172.48% | 5 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 15 15 | 7.47 | 100.8% | 3 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 275 285 | 233.49 | 22.06% | 5 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 6 | n/a | n/a | 10 | Oct 11, 2024 |